These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9027183)

  • 1. [The immunogenicity and heterogeneity of Pseudomonas pseudomallei surface antigen 8].
    Piven' NN; Smirnova VI; Viktorov DV; Kovalenko AA; Farber SM; Iarulin RG; Podzolkova GG
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):75-8. PubMed ID: 9027183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response in experimental animals immunized with Burkholderia pseudomallei surface antigens].
    Avrorova IV; Piven' NN; Zhukova SI; Viktorov DV; Khrapova NP; Popov SF
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):85-9. PubMed ID: 15554321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the surface antigens of Pseudomonas pseudomallei in the pathogenesis of melioidosis].
    Piven' NN; Smirnova VI; Kapliev VI; Podzolkova GG; Khrapova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):8-12. PubMed ID: 1724862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic and protective characteristics of surface antigens 6 and d of Burkholderia pseudomallei].
    Avrorova IV; Korsakova II; Zhukova SI; Khrapova NP; Dem'ianova OB; Lomova LV; Napalkova GM
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):40-4. PubMed ID: 20734717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenic potential of glanders and melioidosis agents].
    Kalachev II; Baídus' AN; Ivanova OA; Ganina EA; Boldyrev IA; Svetoch EA
    Vestn Ross Akad Med Nauk; 1997; (6):32-7. PubMed ID: 9289277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoblot analysis to demonstrate antigenic variability of clinical isolated. Pseudomonas pseudomallei.
    Lertmemongkolchai G; Manmontri W; Leelayuwat C; Romphruk A; Waropastrakul S
    Asian Pac J Allergy Immunol; 1991 Jun; 9(1):5-8. PubMed ID: 1723272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotropic and immunogenic properties of Burkholderia pseudomallei surface and membrane antigens].
    Piven' NN; Rybkin VS; Plekhanova NG; Zhukova SI; Viktorov DV; Avrorova IV; Demediuk EA; Drefs NM; Popov SF
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (1):29-33. PubMed ID: 11236497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens.
    Barnes JL; Ketheesan N
    Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melioidosis vaccines.
    Warawa J; Woods DE
    Expert Rev Vaccines; 2002 Dec; 1(4):477-82. PubMed ID: 12901586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The isolation of the surface antigen from vegetative cells of Bacillus anthracis STI-1 and study of its protective properties].
    Beznosov MV; Petrov GA; Sorkin IuI; Filippova OL; Rogov SN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):9-13. PubMed ID: 9221667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunobiological properties of Burkholderia pseudomallei and Burkholderia mallei capsular substances].
    Popov SF; Tikhonov NG; Piven' NN; Avrorova IV; Viktorov DV; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):60-4. PubMed ID: 12506631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The production of hybridomas producing monoclonal antibodies to the causative agent of melioidosis by using antigen-stimulated lymphocytes in an in-vitro system].
    Titova NG; Razina IV; Sviridov VV; Iakovleva IV; Khrapova NP; Kulakov MIa
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):82-3. PubMed ID: 8553782
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.
    Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenicity of Burkholderia pseudomallei: extracellular and surface antigen functions].
    Piven' NN; Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):94-9. PubMed ID: 11210655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure.
    Yi J; Simpanya MF; Settles EW; Shannon AB; Hernandez K; Pristo L; Keener ME; Hornstra H; Busch JD; Soffler C; Brett PJ; Currie BJ; Bowen RA; Tuanyok A; Keim P
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006851. PubMed ID: 30811382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
    Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins.
    Jones SM; Ellis JF; Russell P; Griffin KF; Oyston PCF
    J Med Microbiol; 2002 Dec; 51(12):1055-1062. PubMed ID: 12466403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.